NACDS to CMS: Finish the Job of DIR Fee Reform NACDS stands up for seniors and pharmacies in comments on Medicare proposed rule
NACDS stands up for seniors and pharmacies in comments on Medicare proposed rule.
With DIR Fee Transparency Rule Finalized, NACDS Urges Continued Push for Comprehensive Reform
NACDS insists that comprehensive DIR fee reform now depends on further legislative and regulatory action to improve predictability, fairness, and viability for pharmacies.
More Than 200 Patient Advocates, Healthcare Entities, Companies Urge Finalized Pharmacy DIR Fee Transparency Rule That Would Promote Patient Access, Protect Pharmacy Viability Groups applaud CMS’ ongoing efforts to address DIR fees; urge further action for comprehensive pharmacy DIR reform that “reduce[s] [Medicare] beneficiary drug costs and also protect[s] pharmacy access”
Groups applaud CMS’ ongoing efforts to address DIR fees; urge further action for comprehensive pharmacy DIR reform that “reduce[s] [Medicare] beneficiary drug costs and also protect[s] pharmacy access”.
New NACDS Report Demonstrates How Leveraging the Expertise and Accessibility of Pharmacists Will Help Support Broader Healthcare Transformation to Advance Quality and Value Calls on the Center for Medicare and Medicaid Innovation to integrate pharmacies and pharmacists into value-based programs and alternative payment models to accelerate mission toward better outcomes and lower costs
Calls on the Center for Medicare and Medicaid Innovation to integrate pharmacies and pharmacists into value-based programs and alternative payment models to accelerate mission toward better outcomes and lower costs.
An “Obvious Miss” for Seniors’ Drug Savings: NACDS Hits Lack of Pharmacy DIR Fee Reform in Current Budget Reconciliation Bill
NACDS today said that omitting pharmacy direct and indirect remuneration (DIR) fee reforms from the Build Back Better Act budget reconciliation bill will deprive Medicare beneficiaries of between $7.1 and $9.2 billion over 10 years in reduced cost-sharing for prescription drugs, according to Centers for Medicare and Medicaid Services (CMS) estimates.
Stakeholders Make Push for Pharmacy DIR Reform 249 organizations sign letter urging Congress to reduce senior drug costs by addressing backdoor pharmacy price concessions
249 organizations sign letter urging Congress to reduce senior drug costs by addressing backdoor pharmacy price concessions.
In Case You Missed It: Government Says DIR Fees That Harm Seniors and Pharmacies Have Skyrocketed by 91,500%
Direct and indirect remuneration (DIR) fees continue to rise at an alarming rate, inflating seniors’ out-of-pocket prescription drug costs and jeopardizing the viability of pharmacies and patient access.
Pharmacy Coalition Praises Legislation to Relieve Patients and Pharmacies from Pharmacy DIR Fees Urges Congress to pass legislation to reduce patients’ out-of-pocket costs and to prevent pharmacy closures jeopardizing patient access
Urges Congress to pass legislation to reduce patients’ out-of-pocket costs and to prevent pharmacy closures jeopardizing patient access.
NACDS Urges Standardized Pharmacy Performance Measures, DIR Fee Reform in Statement to Key House Committee As the House Committee on Energy and Commerce’s Health Subcommittee pursues drug-pricing reform, NACDS also pledges to work with Congress for policies that would not further undermine or complicate pharmacy reimbursement in the Part D program nor potentially harm patients’ access to affordable care
As the House Committee on Energy and Commerce’s Health Subcommittee pursues drug-pricing reform, NACDS also pledges to work with Congress for policies that would not further undermine or complicate pharmacy reimbursement in the Part D program nor potentially harm patients’ access to affordable care
Medicare Proposed Rule Fuels Push for Standardized Pharmacy Quality Program NACDS: Congress must act to reduce patients’ out-of-pocket drug costs, preserve patients’ pharmacy access, and prevent unfair treatment of pharmacies
NACDS: Congress must act to reduce patients’ out-of-pocket drug costs, preserve patients’ pharmacy access, and prevent unfair treatment of pharmacies
